Skip to main content
. 2021 Jul 19;12(1):3566–3577. doi: 10.1080/21655979.2021.1947939

Figure 1.

Figure 1.

STK39 was up-regulated in HCC and predicts poor prognosis

(a) The expression of STK39 in liver hepatocellular carcinoma (LIHC, right group) and normal (left group) tissues was analyzed using GEPIA database. *P < 0.05. (b) The expression of STK39 in different pathological stages of HCC was analyzed using GEPIA database. (c,d) The correlation between STK39 expression and overall survival or disease-free survival of HCC was analyzed using GEPIA database. (E-F) The mRNA and protein expression of STK39 in human normal HHL-5 hepatocytes and human HCC cell lines including MHCC97-H, SK-Hep-1, Huh-7 and Hep3b was tested by RT-qPCR and western blot analysis. *P < 0.05 and ***P < 0.001 vs HHL-5.